Lanean...
Mibefradil, a T‐type Ca(2+) channel blocker also blocks Orai channels by action at the extracellular surface
BACKGROUND AND PURPOSE: Mibefradil, a T‐type Ca(2+) channel blocker, has been investigated for treating solid tumours. However, its underlying mechanisms are still unclear. Here, we have investigated the pharmacological actions of mibefradil on Orai store‐operated Ca(2+) channels. EXPERIMENTAL APPRO...
Gorde:
| Argitaratua izan da: | Br J Pharmacol |
|---|---|
| Egile Nagusiak: | , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
John Wiley and Sons Inc.
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6780027/ https://ncbi.nlm.nih.gov/pubmed/31271653 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.14788 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|